GlassScriptPhysician profile
Lisa A Jacobson
NPI 1922073766
$1,000.08
in general payments reported to CMS, 2019-2025
14 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $84.26 · 2021: $193 · 2022: $92.01 · 2023: $68.32 · 2024: $193 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $271.42 | 2021-2025 | Nucala |
| Acclarent, INC | $129.37 | 2019-2021 | |
| Intersect Ent, INC. | $80.77 | 2019-2021 | |
| Genzyme Corporation | $74.07 | 2023-2024 | |
| Inspire Medical Systems, INC. | $69.21 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $65.22 | 2021-2025 | Keytruda |
| Stryker Corporation | $62.58 | 2019-2021 | |
| Integra Lifesciences Corporation | $61.38 | 2020-2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Convatec INC. | $41.19 | 2025 | |
| Medtronic, INC. | $39.73 | 2024 | Pteye Parathyroid Detection System |
| Novartis Pharmaceuticals Corporation | $37.57 | 2019-2021 | |
| Aerin Medical INC. | $29.75 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $19.84 | 2025 | Tezspire |
| Olympus America INC. | $17.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.